News - Headlands Research

About
Our Sites
CROs & Sponsors
Information Hub
- Blog
- Events
- In the Media
- News
- Resources
Careers
Contact

About
Our Sites
CROs & Sponsors
Information Hub
- Blog
- Events
- In the Media
- News
- Resources
Careers
Contact

News

August 5, 2026

Headlands Research Western Washington branded graphic with a waterfront view of Bellingham, Washington, announcing the addition of the Bellingham site to the research network.

August 5, 2026

Headlands Research Expands Pacific Northwest Presence with New Clinical Research Site in Bellingham, Washington

Read More

August 4, 2026

RSVpreF vaccine study publication featuring Jon Finley, MD, Principal Investigator at Headlands Clinical Research Atlanta.

August 4, 2026

Safety and immunogenicity of bivalent RSVpreF vaccine formulated in a multidose vial in healthy female participants in the USA: a multicentre, randomised, open-label, noninferiority phase 3 study

Read More

July 13, 2026

July 13, 2026

Headlands Research Appoints Young Shon as Chief Information Officer

Read More

June 30, 2026

Graphic announcing Headlands Research's acquisition of Clinical Trials Research, introducing Headlands Research Sacramento and Headlands Research CTR Lincoln.

June 30, 2026

Headlands Research Expands California Presence with Acquisition of Clinical Trials Research

Read More

June 29, 2026

Portrait of Eric Martinson, newly appointed General Counsel at Headlands Research.

June 29, 2026

Headlands Research Appoints Eric Martinson as General Counsel

Read More

June 17, 2026

Featured image promoting a peer-reviewed publication in Advances in Therapy highlighting dupilumab effectiveness in young children with atopic dermatitis regardless of type 2 comorbidities. The graphic features Lawrence Sher, MD, Associate Medical Director and Principal Investigator at Headlands Peninsula Research Associates, as a co-author of the study.

June 17, 2026

Dupilumab is Effective in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities

Read More

May 13, 2026

May 13, 2026

Coadministration of mRNA-1345 RSV vaccine with high-dose quadrivalent influenza vaccine in adults aged 65 and older

Read More

April 14, 2026

Portrait of Maria Nunez, newly appointed Vice President of Patient Recruitment and Marketing at Headlands Research.

April 14, 2026

Headlands Research Appoints Maria Nunez as Vice President of Participant Recruitment and Marketing

Read More

April 8, 2026

Portrait of Ann Mao, newly appointed Chief Operation Officer at Headlands Research.

April 8, 2026

Headlands Research Appoints Ann Mao as Chief Operating Officer

Read More

March 16, 2026

Portrait of Jason Layton, newly appointed Chief Growth Officer at Headlands Research.

March 16, 2026

Headlands Research Appoints Jason Layton as Chief Growth Officer

Read More

Posts pagination

1 2 … 7 →

130 John F Kennedy Dr STE 203 Lake Worth, FL 33462

© 2026 Headlands Research. | Privacy Policy

Facebook
LinkedIn
Twitter
Instagram